Display options
Cite
Sultan A, Rizvi M, Khan F, et al. Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?. Urol Ann. 2015;7(1):26-30doi: 10.4103/0974-7796.148585.
Sultan, A., Rizvi, M., Khan, F., Sami, H., Shukla, I., & Khan, H. M. (2015). Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?. Urology annals, 7(1), 26-30. https://doi.org/10.4103/0974-7796.148585
Sultan, Asfia, et al. "Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?." Urology annals vol. 7,1 (2015): 26-30. doi: https://doi.org/10.4103/0974-7796.148585
Sultan A, Rizvi M, Khan F, Sami H, Shukla I, Khan HM. Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?. Urol Ann. 2015 Jan-Mar;7(1):26-30. doi: 10.4103/0974-7796.148585. PMID: 25657539; PMCID: PMC4310112.
Copy Download .nbib Format: NLM
Share it on

Urol Ann. 2015 Jan-Mar;7(1):26-30. doi: 10.4103/0974-7796.148585.

Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?.

Urology annals

Asfia Sultan, Meher Rizvi, Fatima Khan, Hiba Sami, Indu Shukla, Haris M Khan

Affiliations

  1. Department of Microbiology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

PMID: 25657539 PMCID: PMC4310112 DOI: 10.4103/0974-7796.148585

Abstract

INTRODUCTION: Urinary tract infection (UTI) is one of the most common infectious diseases in clinical practice. The choice of antibiotics for the treatment of UTI is limited by the rising rates of antibiotic resistance. There is an urgent need to discover new effective treatment solutions. Fosfomycin may be an interesting alternative to the currently used treatments of UTIs.

MATERIALS AND METHODS: The study was conducted over 6 months period (January to June 2013) in Department of Microbiology, JNMCH, AMU, Aligarh. A total of 1840 urine samples were submitted. Culture and sensitivity was done as per standard microbiological procedures. Methicillin-resistant Staphylococcus aureus (MRSA), high-level aminoglycoside resistance (HLAR), extended spectrum beta-lactamases (ESBL), AmpC and metallo-beta-lactamases (MBL) production was detected.

RESULTS: Culture was positive in 504 (27.4%) cases. Gram-negative etiology was identified in 390 (73%) cases. ESBL production was detected in 154 (37.1%) while 82 (21.6%) were Amp C. No, MBL was detected. Among Gram-positive bacteria, 68 (51.5%) were MRSA, while 4 (13.3%) were vancomycin resistant enterococci (VRE). HLAR was seen in 53.3% of enterococci. Fosfomycin was effective in 100% of MRSA, VRE, ESBL, HLAR, and overall, susceptibility to fosfomycin in AmpC producers was extremely high (99%). Norfloxacin and cotrimoxazole were not proved effective as only three isolates were sensitive to norfloxacin, while all Gram-negative isolates were resistant to cotrimoxazole. Pseudomonas species showed 65% and 75% susceptibility to colistin and polymixin B, respectively.

CONCLUSION: Fosfomycin has emerged as a promising option, especially in cases involving multi-drug-resistant pathogens in which previous antibiotics have failed to cure the infection.

Keywords: Enterobacteriaceae; fosfomycin; muti-drug resistant; urinary tract infection

References

  1. Clin Microbiol Infect. 2001 Oct;7(10):543-7 - PubMed
  2. Indian J Med Res. 2008 Jan;127(1):85-8 - PubMed
  3. J Chemother. 2010 Oct;22(5):355-7 - PubMed
  4. Nurs Times. 2006 Sep 5-11;102(36):25-6 - PubMed
  5. J Lab Physicians. 2011 Jul;3(2):98-103 - PubMed
  6. Antimicrob Agents Chemother. 2000 Mar;44(3):647-50 - PubMed
  7. J Infect Dis. 2001 Mar 1;183 Suppl 1:S1-4 - PubMed
  8. Tanzan J Health Res. 2010 Oct;12(4):236-40 - PubMed
  9. Antimicrob Agents Chemother. 2009 Oct;53(10):4508-10 - PubMed
  10. J Infect Dev Ctries. 2009 Apr 30;3(3):177-86 - PubMed
  11. Clin Microbiol Infect. 2001 Feb;7(2):88-91 - PubMed
  12. Clin Infect Dis. 1992 Jun;14 Suppl 2:S246-51; discussion S253-4 - PubMed
  13. J Antimicrob Chemother. 2010 Nov;65(11):2459-63 - PubMed
  14. Antimicrob Agents Chemother. 2011 Sep;55(9):4295-301 - PubMed
  15. Antimicrob Agents Chemother. 1991 Jun;35(6):1235-8 - PubMed
  16. Infect Control Hosp Epidemiol. 2006 Aug;27(8):847-54 - PubMed
  17. Lancet Infect Dis. 2010 Jan;10(1):43-50 - PubMed
  18. J Lab Physicians. 2013 Jul;5(2):90-3 - PubMed
  19. Clin Infect Dis. 2008 Apr 1;46(7):1069-77 - PubMed
  20. Scand J Infect Dis. 2003;35(1):12-4 - PubMed

Publication Types